Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening

Brenda C. Timmons, Jeff Reese, Simona Socrate, Noah Ehinger, Bibhash C. Paria, Ginger L. Milne, Meredith L. Akins, Richard J. Auchus, Don McIntire, Michael House, Mala Mahendroo

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Globally, an estimated 13 million preterm babies are born each year. These babies are at increased risk of infant mortality and life-long health complications. Interventions to prevent preterm birth (PTB) require an understanding of processes driving parturition. Prostaglandins (PGs) have diverse functions in parturition, including regulation of uterine contractility and tissue remodeling. Our studiesoncervical remodeling in mice suggest that although local synthesis of PGs are not increased in term ripening, transcripts encoding PG-endoperoxide synthase 2 (Ptgs2) are induced in lipopolysaccharide (LPS)-mediated premature ripening. This study provides evidence for two distinct pathways of cervical ripening: one dependent on PGs derived from paracrine or endocrine sources and the other independent of PG actions. Cervical PG levels are increased in LPS-treated mice, a model of infection-mediated PTB, consistent with increases in PG synthesizing enzymes and reduction in PG-metabolizing enzymes. Administration of SC-236, a PTGS2 inhibitor, along with LPS attenuated cervical softening, consistent with the essential role of PGs in LPS-induced ripening. In contrast, during term and preterm ripening mediated by the antiprogestin, mifepristone, cervical PG levels, and expression of PG synthetic and catabolic enzymes did not change in a manner that supports a role for PGs. These findings in mice, supported by correlative studies in women, suggest PGs do not regulate all aspects of the parturition process. Additionally, it suggests a need to refocus current strategies toward developing therapies for the prevention of PTB that target early, pathway-specific processes rather than focusing on common late end point mediators of PTB.

Original languageEnglish (US)
Pages (from-to)287-298
Number of pages12
JournalEndocrinology
Volume155
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Cervical Ripening
Premature Birth
Prostaglandins
Lipopolysaccharides
Parturition
Enzymes
Synthetic Prostaglandins
Mifepristone
Infant Mortality
Cyclooxygenase 2
Prostaglandin-Endoperoxide Synthases

ASJC Scopus subject areas

  • Endocrinology

Cite this

Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening. / Timmons, Brenda C.; Reese, Jeff; Socrate, Simona; Ehinger, Noah; Paria, Bibhash C.; Milne, Ginger L.; Akins, Meredith L.; Auchus, Richard J.; McIntire, Don; House, Michael; Mahendroo, Mala.

In: Endocrinology, Vol. 155, No. 1, 01.2014, p. 287-298.

Research output: Contribution to journalArticle

Timmons, BC, Reese, J, Socrate, S, Ehinger, N, Paria, BC, Milne, GL, Akins, ML, Auchus, RJ, McIntire, D, House, M & Mahendroo, M 2014, 'Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening', Endocrinology, vol. 155, no. 1, pp. 287-298. https://doi.org/10.1210/en.2013-1304
Timmons, Brenda C. ; Reese, Jeff ; Socrate, Simona ; Ehinger, Noah ; Paria, Bibhash C. ; Milne, Ginger L. ; Akins, Meredith L. ; Auchus, Richard J. ; McIntire, Don ; House, Michael ; Mahendroo, Mala. / Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening. In: Endocrinology. 2014 ; Vol. 155, No. 1. pp. 287-298.
@article{7e7bb21889224c29839b560802508d5a,
title = "Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening",
abstract = "Globally, an estimated 13 million preterm babies are born each year. These babies are at increased risk of infant mortality and life-long health complications. Interventions to prevent preterm birth (PTB) require an understanding of processes driving parturition. Prostaglandins (PGs) have diverse functions in parturition, including regulation of uterine contractility and tissue remodeling. Our studiesoncervical remodeling in mice suggest that although local synthesis of PGs are not increased in term ripening, transcripts encoding PG-endoperoxide synthase 2 (Ptgs2) are induced in lipopolysaccharide (LPS)-mediated premature ripening. This study provides evidence for two distinct pathways of cervical ripening: one dependent on PGs derived from paracrine or endocrine sources and the other independent of PG actions. Cervical PG levels are increased in LPS-treated mice, a model of infection-mediated PTB, consistent with increases in PG synthesizing enzymes and reduction in PG-metabolizing enzymes. Administration of SC-236, a PTGS2 inhibitor, along with LPS attenuated cervical softening, consistent with the essential role of PGs in LPS-induced ripening. In contrast, during term and preterm ripening mediated by the antiprogestin, mifepristone, cervical PG levels, and expression of PG synthetic and catabolic enzymes did not change in a manner that supports a role for PGs. These findings in mice, supported by correlative studies in women, suggest PGs do not regulate all aspects of the parturition process. Additionally, it suggests a need to refocus current strategies toward developing therapies for the prevention of PTB that target early, pathway-specific processes rather than focusing on common late end point mediators of PTB.",
author = "Timmons, {Brenda C.} and Jeff Reese and Simona Socrate and Noah Ehinger and Paria, {Bibhash C.} and Milne, {Ginger L.} and Akins, {Meredith L.} and Auchus, {Richard J.} and Don McIntire and Michael House and Mala Mahendroo",
year = "2014",
month = "1",
doi = "10.1210/en.2013-1304",
language = "English (US)",
volume = "155",
pages = "287--298",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Prostaglandins are essential for cervical ripening in LPS-Mediated preterm birth but not term or antiprogestin-driven preterm ripening

AU - Timmons, Brenda C.

AU - Reese, Jeff

AU - Socrate, Simona

AU - Ehinger, Noah

AU - Paria, Bibhash C.

AU - Milne, Ginger L.

AU - Akins, Meredith L.

AU - Auchus, Richard J.

AU - McIntire, Don

AU - House, Michael

AU - Mahendroo, Mala

PY - 2014/1

Y1 - 2014/1

N2 - Globally, an estimated 13 million preterm babies are born each year. These babies are at increased risk of infant mortality and life-long health complications. Interventions to prevent preterm birth (PTB) require an understanding of processes driving parturition. Prostaglandins (PGs) have diverse functions in parturition, including regulation of uterine contractility and tissue remodeling. Our studiesoncervical remodeling in mice suggest that although local synthesis of PGs are not increased in term ripening, transcripts encoding PG-endoperoxide synthase 2 (Ptgs2) are induced in lipopolysaccharide (LPS)-mediated premature ripening. This study provides evidence for two distinct pathways of cervical ripening: one dependent on PGs derived from paracrine or endocrine sources and the other independent of PG actions. Cervical PG levels are increased in LPS-treated mice, a model of infection-mediated PTB, consistent with increases in PG synthesizing enzymes and reduction in PG-metabolizing enzymes. Administration of SC-236, a PTGS2 inhibitor, along with LPS attenuated cervical softening, consistent with the essential role of PGs in LPS-induced ripening. In contrast, during term and preterm ripening mediated by the antiprogestin, mifepristone, cervical PG levels, and expression of PG synthetic and catabolic enzymes did not change in a manner that supports a role for PGs. These findings in mice, supported by correlative studies in women, suggest PGs do not regulate all aspects of the parturition process. Additionally, it suggests a need to refocus current strategies toward developing therapies for the prevention of PTB that target early, pathway-specific processes rather than focusing on common late end point mediators of PTB.

AB - Globally, an estimated 13 million preterm babies are born each year. These babies are at increased risk of infant mortality and life-long health complications. Interventions to prevent preterm birth (PTB) require an understanding of processes driving parturition. Prostaglandins (PGs) have diverse functions in parturition, including regulation of uterine contractility and tissue remodeling. Our studiesoncervical remodeling in mice suggest that although local synthesis of PGs are not increased in term ripening, transcripts encoding PG-endoperoxide synthase 2 (Ptgs2) are induced in lipopolysaccharide (LPS)-mediated premature ripening. This study provides evidence for two distinct pathways of cervical ripening: one dependent on PGs derived from paracrine or endocrine sources and the other independent of PG actions. Cervical PG levels are increased in LPS-treated mice, a model of infection-mediated PTB, consistent with increases in PG synthesizing enzymes and reduction in PG-metabolizing enzymes. Administration of SC-236, a PTGS2 inhibitor, along with LPS attenuated cervical softening, consistent with the essential role of PGs in LPS-induced ripening. In contrast, during term and preterm ripening mediated by the antiprogestin, mifepristone, cervical PG levels, and expression of PG synthetic and catabolic enzymes did not change in a manner that supports a role for PGs. These findings in mice, supported by correlative studies in women, suggest PGs do not regulate all aspects of the parturition process. Additionally, it suggests a need to refocus current strategies toward developing therapies for the prevention of PTB that target early, pathway-specific processes rather than focusing on common late end point mediators of PTB.

UR - http://www.scopus.com/inward/record.url?scp=84891412594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891412594&partnerID=8YFLogxK

U2 - 10.1210/en.2013-1304

DO - 10.1210/en.2013-1304

M3 - Article

C2 - 24189143

AN - SCOPUS:84891412594

VL - 155

SP - 287

EP - 298

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 1

ER -